Cargando…

Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products

New technologies and our ever-increasing knowledge provide an exciting potential to develop innovative health products that can address challenges such as chronic diseases and ultimately improve outcomes for patients. Ireland has a strategic focus on supporting innovation and offers an ideal environ...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Dwyer, Laurence, Nolan, Lorraine, Fisher, Caitriona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945904/
https://www.ncbi.nlm.nih.gov/pubmed/31988952
http://dx.doi.org/10.1159/000481427
_version_ 1783485256856240128
author O'Dwyer, Laurence
Nolan, Lorraine
Fisher, Caitriona
author_facet O'Dwyer, Laurence
Nolan, Lorraine
Fisher, Caitriona
author_sort O'Dwyer, Laurence
collection PubMed
description New technologies and our ever-increasing knowledge provide an exciting potential to develop innovative health products that can address challenges such as chronic diseases and ultimately improve outcomes for patients. Ireland has a strategic focus on supporting innovation and offers an ideal environment for health product innovation. This is due to the expertise and experience that is available within the life sciences sector and an established national infrastructure which supports the translation of research into health products in a collaborative manner. The Health Products Regulatory Authority (HPRA) is committed to supporting innovation for health products. Anyone developing an innovative health product can obtain regulatory guidance via the HPRA's Innovation Office. Scientific advice and a product classification service are also available. The HPRA is actively engaging with innovators through an outreach programme to discuss how regulation can support innovation and to raise awareness of available supports. In order to facilitate the appropriate regulation of innovative therapies, the HPRA is performing horizon scanning to identify innovations at an early stage of development, so that proactive action can be taken to put in place any additional regulatory tools or develop any expertise required to regulate such products and provide safe and timely access for patients.
format Online
Article
Text
id pubmed-6945904
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-69459042020-01-27 Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products O'Dwyer, Laurence Nolan, Lorraine Fisher, Caitriona Biomed Hub Article New technologies and our ever-increasing knowledge provide an exciting potential to develop innovative health products that can address challenges such as chronic diseases and ultimately improve outcomes for patients. Ireland has a strategic focus on supporting innovation and offers an ideal environment for health product innovation. This is due to the expertise and experience that is available within the life sciences sector and an established national infrastructure which supports the translation of research into health products in a collaborative manner. The Health Products Regulatory Authority (HPRA) is committed to supporting innovation for health products. Anyone developing an innovative health product can obtain regulatory guidance via the HPRA's Innovation Office. Scientific advice and a product classification service are also available. The HPRA is actively engaging with innovators through an outreach programme to discuss how regulation can support innovation and to raise awareness of available supports. In order to facilitate the appropriate regulation of innovative therapies, the HPRA is performing horizon scanning to identify innovations at an early stage of development, so that proactive action can be taken to put in place any additional regulatory tools or develop any expertise required to regulate such products and provide safe and timely access for patients. S. Karger AG 2017-11-21 /pmc/articles/PMC6945904/ /pubmed/31988952 http://dx.doi.org/10.1159/000481427 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Article
O'Dwyer, Laurence
Nolan, Lorraine
Fisher, Caitriona
Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products
title Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products
title_full Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products
title_fullStr Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products
title_full_unstemmed Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products
title_short Supporting Innovation through Regulation and Science: Ireland as an Innovation Hub for Health Products
title_sort supporting innovation through regulation and science: ireland as an innovation hub for health products
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945904/
https://www.ncbi.nlm.nih.gov/pubmed/31988952
http://dx.doi.org/10.1159/000481427
work_keys_str_mv AT odwyerlaurence supportinginnovationthroughregulationandscienceirelandasaninnovationhubforhealthproducts
AT nolanlorraine supportinginnovationthroughregulationandscienceirelandasaninnovationhubforhealthproducts
AT fishercaitriona supportinginnovationthroughregulationandscienceirelandasaninnovationhubforhealthproducts